High-Cost Drug Reimbursement
Customize your policy alerts
Sign up for wellfleet Policy GL-023 alerts
Get alerted when Policy GL-023 changes without checking for updates manually.
Monitor payer policy activity
This payment guideline governs reimbursement for high-cost drugs billed under a member's medical benefit when the drugs are separately reimbursable from other claim line items. It applies to eligible Wellfleet plans and requires covered status, appropriate coding, applicable precertification, and satisfaction of the guideline's reimbursement conditions.
No material clinical or coverage changes in this revision.
High-Cost Drug Reimbursement Conditions
Conditions for high-cost drug reimbursement
Wellfleet will reimburse up to two times the listed AWP for a high-cost drug on a medical claim only when all of the following conditions are met:
ALL of the following
- The high-cost drug is covered under the medical benefit for an eligible member's plan.
- The high-cost drug is billed as an individual line item on a medical claim.
- The high-cost drug is appropriately coded as specifically as possible at the time of billing.
- The claim payment methodology requires the high-cost drug to be reimbursed separately from other line items, including applicable percent-of-charges, Reasonable, Customary & Usual, or revenue-code carve-out methodologies.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.